サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1136913

患者登録ソフトウェアの世界市場-2022-2029

Global Patient Registry Software Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
患者登録ソフトウェアの世界市場-2022-2029
出版日: 2022年10月13日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

患者登録ソフトウェア市場の成長は、政府の取り組み、病気の診断のための患者登録ソフトウェアの採用の増加、研究開発活動によってもたらされます。

電子健康記録（EHR）の受け入れが市場成長を促進すると予想されます。

デジタルの世界では、ビッグデータと膨大な健康情報を扱うために、情報通信技術がヘルスケア産業で一般的に使用され、広範囲に利用されています。国際標準化機構（ISO）によると、EHRはデジタル形式の患者データのリポジトリとみなされ、安全に保存・交換され、複数の権限を持つユーザーがアクセスできるようになっています。このシステムをヘルスケア分野に採用することで、患者ケアの向上、コストの最小化、収益の増加、医療過誤の減少、ファイルスペースの必要性の減少、データの機密性、患者データの中央管理、医療情報の共有など、いくつかの利点があります。さらに、EHRを利用することで、臨床医は患者データを容易に分析し、新しい治療法の発見、安全性の問題の発見、異常な臨床所見の特定を行うことができます。

さらに、市場参加者は、製品の発売やコラボレーションなど、さまざまな市場戦略を採用しています。例えば、2020年10月、Dacima Software, Inc.は、Movember社と共同で、世界最大の前立腺がん患者レジストリネットワークを立ち上げるために、新しいレジストリデータベースを設計・開発しました。また、2020年6月には、ArborMetrix Inc.（米国）がThe Society of Interventional Radiology（SIR）（米国）とパートナーシップを結びました。この提携目標は、IR Quality Registryに、アナリティクスを統合して患者ケアを向上させる方法を提供することです。

患者登録ソフトウェアの高コストが市場成長の妨げとなる

しかし、世界中の電子記録プロジェクトの50％以上が、目標とする利益を提供することなく失敗しています。特に、サハラ砂漠以南の低所得国のヘルスケア分野では、EHRの導入が大きな課題として残っています。低所得国のうち、医療機関に電子記録システムを全国的に導入しているのは、わずか15%に過ぎません。

COVID-19の影響分析

COVID-19の登場は、世界の患者登録ソフトウェア市場に大きな影響を与えました。COVID-19の流行が始まった当初から、その複雑で特定できない性質を持つCOVID-19の迅速で驚くべき発生は、データ収集インフラを作り、世界中で基本的な必要性を持つようになったのです。市場関係者は、データ管理のためのソリューションの開発に従事しました。例えば、2020年3月、データと分析の技術とサービスを提供するHealth Catalyst, Inc.は、COVID-19レジストリ、ダッシュボード、およびキャパシティプランニングツールを発表しました。さらに、政府はCOVID-19の状況をコントロールし、管理することをサポートしています。例えば、イランでは、COVID-19の流行の初期に、保健システムの管理者である保健省は、ヘルスケアセンターでCOVID-19に対処するための2つの情報システムを作成しました。しかし、この2つのシステムは、COVID-19の患者に関する基本的な情報を収集するものです。全体として、COVID-19は市場の成長にプラスの影響を与えました。

世界の患者登録ソフトウェア市場レポートでは、約65以上の市場データ表、65以上の図、200以上のページ（概算）の範囲でのアクセスを提供することになります。

目次

第1章 市場調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場影響要因
    • 促進要因
      • EHRと情報技術関連サービスの導入の増加
      • 慢性疾患の増加別、ヘルスケアマネジメントの高度化
    • 抑制要因
      • プライバシー、データセキュリティ関連の問題、熟練・訓練されたリソースの不足
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析
  • プライシング分析
  • アンメットニーズ分析

第6章 COVID-19分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、あるいは将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 疾患登録タイプ別

  • アルツハイマー型認知症
  • 糖尿病
  • 整形外科
  • 循環器
  • 癌
  • その他

第8章 機能タイプ別

  • 患者ケアマネジメント
  • 医療情報交換（HIC）
  • ポイントオブケア（POC）
  • 調査・研究
  • その他

第9章 エンドユーザー別

  • 病院
  • 製薬会社
  • 臨床検査機関
  • その他

第10章 ソフトウェアタイプ別

  • 統合型
  • スタンドアロン

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 治療タイプ別ベンチマーク

第13章 企業プロファイル

  • Dacima Software Inc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • McKesson Corporation
  • Global Vision Technologies Inc.
  • ImageTrend Inc.
  • Liaison Technologies.
  • Optum Inc.
  • Phytel Inc.
  • Quintiles IMS Holdings Inc

第14章 患者登録ソフトウェアの世界市場-データM

目次
Product Code: DMHCIT825

Market Overview

Patient Registry Software Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 9.2% during the forecast period (2022-2029).

Patient registry software is an automated database containing personal, medical, social, and financial data reported by healthcare professionals or patients. In addition, this software easily collects data on patients or groups of patients in clinical studies, taking a new drug or having a particular diagnosis or condition.

Market Dynamics

The patient registry software market growth is driven by government initiatives, the rising adoption of patient registry softwares for the diagnosis of disease, increase and research and development activities.

The acceptance of Electronic Health Records (EHR) is expected to drive the market growth

In the digital world, information communication technologies are commonly used and extensive in the healthcare industry to handle big data and ample health information. According to the International Organization for Standardization (ISO), EHR is considered a repository of patient data in digital form, stored and exchanged securely and accessible by multiple authorized users. Adopting this system in the healthcare sector has several advantages, such as improving patient care, minimizing cost, increasing revenue, reducing medical errors, reducing the need for file space, data confidentiality, central patient data management, and sharing medical information. In addition, the EHR enables clinicians to easily analyze patient data to discover new treatments, uncover safety issues, and identify unusual clinical findings.

In addition, the market players are adopting different market strategies, including product launches and collaboration. For instance, in October 2020, Dacima Software, Inc., with Movember, designed and developed a new registry database to launch the world's largest prostate cancer patient registry network. Also, in June 2020, ArborMetrix Inc. (US) partnered with The Society of Interventional Radiology (SIR) (US). This partnership goal is to provide the IR Quality Registry with a way to improve patient care by integrating analytics.

The high cost of Patient Registry Software will hamper the growth of the market

However, more than 50% of electronic record projects worldwide failed without providing their targeted benefits. Especially the implementation of EHR remains a major challenge in the healthcare sector in low-income countries such as Sub-Saharan countries. Merely 15% of low-income countries have nationally adopted electronic record systems in health institutions.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global patient registry software market. From the beginning of the COVID-19 pandemic, the fast and surprising outbreak of COVID-19, its complex and unspecified nature has created data collection infrastructures and has become a fundamental necessity worldwide. The market players engaged in developing solutions for the management of data. For instance, in March 2020, Health Catalyst, Inc., a provider of data and analytics technology and services, launched a COVID-19 Registry, Dashboard, and Capacity Planning Tool. In addition, the government supports controlling and managing the situation of COVID-19. For instance, in Iran, at the beginning of the COVID-19 epidemic, the Ministry of Health, as the custodian of the health system, created two information systems for addressing COVID-19 in healthcare centers. However, these two systems collect basic information about patients with COVID-19. Overall, COVID-19 positively impacted market growth.

Segment Analysis

The Point Of Care (POC) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The Point Of Care (POC) segment is expected to boost the market over the forecast period. As per the article published in Practical Laboratory Medicine in November 2020, Accreditation and regulatory standards highlight the rising need to integrate POC Testing results into the patient's electric medical records. This promotes accessibility of POC results, the ability to monitor and trend, prevents unnecessary repeat testing and provides evidence for patient outcomes. As POC results are used to make clinical decisions, it is important to document results with associated reference intervals, units of measurement, critical values if applicable, date and time of testing, and also be traceable to device serial number, operator identification number, reagent lot number, and quality control (QC) results. POC results should also be differentiated from other central laboratory results to avoid confusion and trending results from different analytical methodologies. POC is routine in all hospitals and has become the standard for patient care in various healthcare settings.

Geographical Analysis

North America region holds the largest market share of the global patient registry software market

North America dominates the market for Patient Registry Software and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to increasing government support for the development, advanced healthcare infrastructure and point-of-care management. The development of digital infrastructure in the healthcare sector and the adoption of technological advancements by healthcare professionals and staff drive the market in the North American region.

For instance, in April 2020, the American Heart Association declared the development of a new patient registry to collect data. It helps the researchers to understand the interconnection between coronavirus, cardiovascular diseases, and related treatment protocols. Also, in February 2021, the Leukemia & Lymphoma Society (LLS) partnered with Citizen to develop a digital health solution to study the relationship between coronavirus and vaccination amongst blood cancer patients. They established LLS National Patient Registry to collect data on blood cancer patients for the study.

In addition, the market players are adopting product launches and collaboration strategies to expand their business in the North American region. For instance, in March 2021, ESO Solutions partnered with Virginia EMS Systems to deliver a statewide EMS data repository and statewide trauma registry to collect and analyze data to reveal key insights and trends. Also, in November 2020, ArborMetrix, Inc. partnered with the American Academy of Pediatrics to develop and grow a clinical registry to advance all children's health, well-being, and development.

Competitive Landscape

The patient registry software market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Dacima Software Inc, McKesson Corporation, Global Vision Technologies Inc., ImageTrend Inc., Liaison Technologies, Optum Inc., Phytel Inc., and Quintiles IMS Holdings Inc, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global patient registry software market.

For instance,

  • In December 2020, ImageTrend, Inc. announced the latest National Trauma Data Bank (NTDB) Data Dictionary available in the Patient Registry on January 2021.

Dacima Software Inc

Overview:

Dacima Software is a flexible company founded in 2003 and has developed advanced clinical software that helps solve the business's major strategic and operational challenges.

Product Portfolio:

DACIMA REGISTRY: The Dacima REGISTRY is a modified database creation software that permits users to produce registries and administrative databases without expertise in computer programming or database design theory.

The global Patient Registry Software market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase In Adoption Of EHR's And Information Technology Related Services
      • 4.1.1.2. Increase In The Prevalence Of The Chronic Disease Lead To Advancements In Healthcare Management
    • 4.1.2. Restraints:
      • 4.1.2.1. Privacy, Data Security-Related Issues And Lack Of Availability Of Skilled & Trained Resources
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Disease Registry Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 7.1.2. Market Attractiveness Index, By Disease Registry Type
  • 7.2. Alzheimer's Disease *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Diabetes
  • 7.4. Orthopaedics
  • 7.5. Cardiovascular
  • 7.6. Cancer
  • 7.7. Others

8. By Functionality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 8.1.2. Market Attractiveness Index, By Functionality Type
  • 8.2. Patient Care Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Health Information Exchange (HIC)
  • 8.4. Point Of Care (POC)
  • 8.5. Research
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pharmaceutical companies
  • 9.4. Clinical laboratories
  • 9.5. Others

10. By Software Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 10.1.2. Market Attractiveness Index, By Software Type
  • 10.2. Integrated*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Stand-alone

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Treatment type Benchmarking

13. Company Profiles

  • 13.1. Dacima Software Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. McKesson Corporation
  • 13.3. Global Vision Technologies Inc.
  • 13.4. ImageTrend Inc.
  • 13.5. Liaison Technologies.
  • 13.6. Optum Inc.
  • 13.7. Phytel Inc.
  • 13.8. Quintiles IMS Holdings Inc

LIST NOT EXHAUSTIVE

14. Global Patient Registry Software market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us